Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...

On the eve of his Tate Modern survey, Ed Atkins reflects on avatars, affect and why writing remains at the core of his ...

Vice President JD Vance, his wife and other senior U.S. officials are due to visit an American military base in Greenland on ...

Researchers assessed data from 16 million patients from 2006 to 2020 taking semaglutide-based drugs; the active ingredient in ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

In a 'Self' interview published on March 26, the influencer, 30, revealed that her drastic weight loss was due to bariatric surgery Zoey Lyttle is a Society & Culture Writer-Reporter at PEOPLE.

Ozempic (semaglutide) is a prescription drug that some doctors may prescribe off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight loss and weight ...

The former NFL player revealed on that he's currently competing in a weight loss challenge against friend and former Eagles teammate Beau Allen. "It's kind of embarrassing seeing your body broken ...